Cetera Advisor Networks LLC trimmed its stake in AmerisourceBergen Corp. (NYSE:ABC) by 5.7% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 6,673 shares of the company’s stock after selling 405 shares during the period. Cetera Advisor Networks LLC’s holdings in AmerisourceBergen were worth $496,000 at the end of the most recent reporting period.
Other large investors also recently bought and sold shares of the company. Acima Private Wealth LLC bought a new stake in shares of AmerisourceBergen in the 4th quarter valued at approximately $26,000. Private Capital Group LLC lifted its stake in shares of AmerisourceBergen by 201.3% in the 4th quarter. Private Capital Group LLC now owns 482 shares of the company’s stock valued at $36,000 after purchasing an additional 322 shares during the last quarter. JNBA Financial Advisors bought a new stake in shares of AmerisourceBergen during the 4th quarter worth approximately $37,000. Oregon Public Employees Retirement Fund lifted its stake in shares of AmerisourceBergen by 6,614.4% during the 4th quarter. Oregon Public Employees Retirement Fund now owns 3,448,589 shares of the company’s stock worth $46,000 after acquiring an additional 3,397,228 shares during the last quarter. Finally, Financial Gravity Companies Inc. purchased a new position in AmerisourceBergen during the 4th quarter worth $54,000. 66.48% of the stock is owned by institutional investors and hedge funds.
In other news, CEO Steven H. Collis sold 21,350 shares of AmerisourceBergen stock in a transaction on Wednesday, January 2nd. The stock was sold at an average price of $73.96, for a total value of $1,579,046.00. Following the transaction, the chief executive officer now directly owns 155,929 shares in the company, valued at approximately $11,532,508.84. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Steven H. Collis sold 21,344 shares of AmerisourceBergen stock in a transaction on Friday, March 1st. The shares were sold at an average price of $83.62, for a total value of $1,784,785.28. Following the completion of the transaction, the chief executive officer now owns 155,923 shares in the company, valued at $13,038,281.26. The disclosure for this sale can be found here. Over the last quarter, insiders bought 2,018 shares of company stock worth $156,471 and sold 110,411 shares worth $8,978,127. Company insiders own 27.80% of the company’s stock.
AmerisourceBergen (NYSE:ABC) last announced its quarterly earnings results on Thursday, January 31st. The company reported $1.60 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $1.50 by $0.10. AmerisourceBergen had a return on equity of 44.53% and a net margin of 0.69%. The business had revenue of $45.39 billion for the quarter, compared to the consensus estimate of $43.52 billion. On average, equities research analysts forecast that AmerisourceBergen Corp. will post 6.76 EPS for the current year.
The business also recently declared a quarterly dividend, which was paid on Monday, March 4th. Stockholders of record on Tuesday, February 19th were issued a $0.40 dividend. The ex-dividend date was Friday, February 15th. This represents a $1.60 dividend on an annualized basis and a dividend yield of 2.02%. AmerisourceBergen’s dividend payout ratio is presently 24.65%.
Several research analysts have commented on the company. Zacks Investment Research downgraded AmerisourceBergen from a “hold” rating to a “sell” rating in a report on Monday, March 25th. TheStreet downgraded AmerisourceBergen from a “b” rating to a “c+” rating in a report on Tuesday, March 19th. ValuEngine downgraded AmerisourceBergen from a “hold” rating to a “sell” rating in a report on Monday, February 25th. UBS Group assumed coverage on AmerisourceBergen in a report on Thursday, January 17th. They set a “buy” rating and a $89.00 price objective on the stock. Finally, Barclays restated a “hold” rating and set a $84.00 price objective on shares of AmerisourceBergen in a report on Sunday, January 6th. Two equities research analysts have rated the stock with a sell rating, five have given a hold rating and one has given a buy rating to the stock. The company presently has an average rating of “Hold” and an average target price of $88.33.
TRADEMARK VIOLATION NOTICE: This story was first reported by Sports Perspectives and is the property of of Sports Perspectives. If you are viewing this story on another domain, it was illegally copied and reposted in violation of US and international trademark and copyright legislation. The correct version of this story can be accessed at https://sportsperspectives.com/2019/04/02/cetera-advisor-networks-llc-has-496000-stake-in-amerisourcebergen-corp-abc.html.
AmerisourceBergen Company Profile
AmerisourceBergen Corporation sources and distributes pharmaceutical products in the United States and internationally. Its Pharmaceutical Distribution segment distributes brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, outsourced compounded sterile preparations, and related services to various healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and other alternate site pharmacies, and other customers.
Recommended Story: Book Value Per Share in Stock Trading
Want to see what other hedge funds are holding ABC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for AmerisourceBergen Corp. (NYSE:ABC).
Receive News & Ratings for AmerisourceBergen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AmerisourceBergen and related companies with MarketBeat.com's FREE daily email newsletter.